Andrey_Karamyshev-3.jpg (IMAGE)

Texas Tech University Health Sciences Center

Andrey_Karamyshev-3.jpg

Caption

TTUHSC’s Andrey Karamyshev, Ph.D., received a two-year grant from the National Cancer Institute to investigate new approaches to inhibit STAT3, a protein associated with approximately 70% of all human tumors.

Credit

TTUHSC

Usage Restrictions

None

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.